Gaorong Ventures — Full Portfolio
5 tracked investments · listed companies and verified rows first
ProNovo Therapeutics is a biotechnology company developing precision small-molecule therapeutics for neuropsychiatric disorders, including Major Depressive Disorder and Schizophrenia.
BiotechHealthtechMental Health
Guang Chen(Founder, Board Director & Chief Scientific Officer)inXiaohu Deng(Co-Founder & CEO)inScott Thompson(Co-Founder & Chair of Scientific Advisory Board)in
Co-investors3E Bioventures Capital
Arnatar develops a next-generation RNA discovery platform called DARGER that combines gene silencing and gene upregulation technologies for oligonucleotide therapeutics.
AI & Machine LearningBiotechDeep Tech
Dr. Xuehai Liang(Founder)Dr. Yanfeng Wang(Founder & Chief Operating Officer)
Co-investors3E Bioventures CapitalF-Prime CapitalApricot CapitalEight Roads VenturesLegend StarNew Alliance Capital
Axoft is developing soft, tissue-mimicking neural implants and supporting bidirectional electronics that record and stimulate brain activity through a minimally-invasive burr-hole procedure.
AI & Machine LearningDeep TechMedical DevicesCambridge, US
Paul Le Floch(Executive Officer, Director)inTianyang Ye(Director)inRachel Sha(Director)in
BoardChia An Lee(Director)Benjamin Pless(Director)
Co-investorsArcherman CapitalBlindspot Ventures Management CoCastor VenturesCreative Destruction Lab (CDL)Safar PartnersThe Engine Ventures+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Sirqul凌迪Style3D
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.